.jpg)
Standard or Abbreviated Antiplatelet Therapy for Patients with Diabetes and High Bleeding Risk?
These findings suggest that a shorter duration of antiplatelet therapy may be a safe and effective strategy for these patients, but further research is needed to confirm these findings and identify optimal patient subgroups.